File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Anti-heat-shock proteins 65 and 70 antibodies in patients with vascular diseases

TitleAnti-heat-shock proteins 65 and 70 antibodies in patients with vascular diseases
Authors
Issue Date1998
PublisherSpringer Netherlands.
Citation
The 1998 International Conference on Heat-Shock Proteins in Immune Response, Farmington, CT., 12-15 October 1998. In Cell Stress & Chaperones, v. 3 suppl 1, p. 14 How to Cite?
AbstractIntroduction/Aim. Recent evidence suggests that the immune system plays an essential role in the pathogenesis of atherosclerosis with involvement of both cellular and humoral mechanisms. Heat-shock proteins (Hsps) have been detected in atherosclerotic lesions of subjects with carotid and coronary artery stenoses. In addition anti-Hsp antibody levels were raised in these patients. The aim of this study was to examine the level of anti-Hsp65 and 70 antibodies in patients with different vascular diseases. Materials/MethodsA. questionnaire was designed for the subjects in the study, with documentation of clinical details. Patients with concomitant infection, malignancy, hepatorenal failure, or recent surgery were excluded and all groups were age-matched. Subject groups consisted of controls (n = 21), patients with abdominal aortic aneurysms (AAA, n = 20), stable claudication (SC, n = 19) and lower limb critical ischaemia (CI, n = 18). An ELISA was used to identify anti-Hsp65 and 70 antibodies in the sera in different dilutions. Graphs of Optical Density (OD) vs negative log dilution were plotted, the gradient of which was taken to be the Estimated Optical Density (EOD) for each subject (proportional to antibody level). Results. Anti-Hsp65 antibody levels were not found to be significantly different [Mann-Whitney, P= 0.8550 (AAA), 0.5430 (SC), 0.3200 (CI), respectively] from the control. In contrast, anti-Hsp70 antibody levels in patients with AAA, SC and CI were significantly (Mann-Whitney, P= 0.0008, 0.0127, 0.0037, respectively) higher than controls. In both cases no correlation was found between age and EOD (Spearman, Hsp65: R = 0.0087, P= 0.9393, Hsp7O: R= 0.1204, P= 0.1407). Conclusions. These data demonstrate no difference in anti-Hsp65 antibodies levels in different vascular conditions. There is, however, a strong correlation between anti-Hsp70 antibodies and different types of vascular diseases, suggesting that Hsp70 might be involved in the pathogenesis and propagation of atherosclerosis. Since the immune response to Hsps can be modulated, this may open new possibilities for therapeutic approaches.
DescriptionStable URL: http://www.jstor.org/stable/3515900
Persistent Identifierhttp://hdl.handle.net/10722/148728
ISSN
2015 Impact Factor: 2.583
2015 SCImago Journal Rankings: 1.276

 

DC FieldValueLanguage
dc.contributor.authorChan, YC-
dc.contributor.authorAbdus-Samee, M-
dc.contributor.authorShukla, N-
dc.contributor.authorBerwanger, CS-
dc.contributor.authorStanford, J-
dc.contributor.authorSingh, M-
dc.contributor.authorMansfield, AO-
dc.contributor.authorStansby, G-
dc.date.accessioned2012-05-30T01:30:59Z-
dc.date.available2012-05-30T01:30:59Z-
dc.date.issued1998-
dc.identifier.citationThe 1998 International Conference on Heat-Shock Proteins in Immune Response, Farmington, CT., 12-15 October 1998. In Cell Stress & Chaperones, v. 3 suppl 1, p. 14-
dc.identifier.issn1355-8145-
dc.identifier.urihttp://hdl.handle.net/10722/148728-
dc.descriptionStable URL: http://www.jstor.org/stable/3515900-
dc.description.abstractIntroduction/Aim. Recent evidence suggests that the immune system plays an essential role in the pathogenesis of atherosclerosis with involvement of both cellular and humoral mechanisms. Heat-shock proteins (Hsps) have been detected in atherosclerotic lesions of subjects with carotid and coronary artery stenoses. In addition anti-Hsp antibody levels were raised in these patients. The aim of this study was to examine the level of anti-Hsp65 and 70 antibodies in patients with different vascular diseases. Materials/MethodsA. questionnaire was designed for the subjects in the study, with documentation of clinical details. Patients with concomitant infection, malignancy, hepatorenal failure, or recent surgery were excluded and all groups were age-matched. Subject groups consisted of controls (n = 21), patients with abdominal aortic aneurysms (AAA, n = 20), stable claudication (SC, n = 19) and lower limb critical ischaemia (CI, n = 18). An ELISA was used to identify anti-Hsp65 and 70 antibodies in the sera in different dilutions. Graphs of Optical Density (OD) vs negative log dilution were plotted, the gradient of which was taken to be the Estimated Optical Density (EOD) for each subject (proportional to antibody level). Results. Anti-Hsp65 antibody levels were not found to be significantly different [Mann-Whitney, P= 0.8550 (AAA), 0.5430 (SC), 0.3200 (CI), respectively] from the control. In contrast, anti-Hsp70 antibody levels in patients with AAA, SC and CI were significantly (Mann-Whitney, P= 0.0008, 0.0127, 0.0037, respectively) higher than controls. In both cases no correlation was found between age and EOD (Spearman, Hsp65: R = 0.0087, P= 0.9393, Hsp7O: R= 0.1204, P= 0.1407). Conclusions. These data demonstrate no difference in anti-Hsp65 antibodies levels in different vascular conditions. There is, however, a strong correlation between anti-Hsp70 antibodies and different types of vascular diseases, suggesting that Hsp70 might be involved in the pathogenesis and propagation of atherosclerosis. Since the immune response to Hsps can be modulated, this may open new possibilities for therapeutic approaches.-
dc.languageeng-
dc.publisherSpringer Netherlands.-
dc.relation.ispartofCell Stress & Chaperones-
dc.rightsThe original publication is available at www.springerlink.com-
dc.titleAnti-heat-shock proteins 65 and 70 antibodies in patients with vascular diseasesen_US
dc.typeConference_Paperen_US
dc.identifier.emailChan, YC: ycchan88@hkucc.hku.hk-
dc.identifier.volume3-
dc.identifier.issuesuppl. 1-
dc.identifier.spage14-
dc.identifier.epage14-
dc.publisher.placeThe Netherlands-
dc.customcontrol.immutablesml 160630 amended-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats